E. Ohman J or Asset Management AB Acquires 354,730 Shares of Colgate-Palmolive (NYSE:CL)

E. Ohman J or Asset Management AB increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 1,108.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 386,730 shares of the company’s stock after buying an additional 354,730 shares during the period. E. Ohman J or Asset Management AB’s holdings in Colgate-Palmolive were worth $35,158,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in CL. FMR LLC lifted its stake in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the last quarter. Barclays PLC lifted its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the last quarter. State Street Corp grew its stake in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the period. Nordea Investment Management AB increased its holdings in Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock worth $462,121,000 after acquiring an additional 1,247,731 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. raised its stake in Colgate-Palmolive by 864.1% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock valued at $80,749,000 after acquiring an additional 697,168 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.4 %

NYSE CL opened at $87.05 on Tuesday. The stock’s 50-day simple moving average is $91.35 and its two-hundred day simple moving average is $97.15. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $71.12 billion, a price-to-earnings ratio of 24.73, a PEG ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business posted $0.87 earnings per share. Research analysts forecast that Colgate-Palmolive will post 3.74 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. UBS Group cut their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, Piper Sandler dropped their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.